Before another heart operation, rebuild the full surgical map.

Redo heart surgery, also called reoperative cardiac surgery, is another heart operation after a prior cardiac operation. It may involve repeat sternotomy or another access route and can address a valve, coronary bypass grafts, the aorta, infection, a prior repair, an implanted device, or several problems together. “Redo” describes the prior surgical field; it does not identify one procedure or one level of risk.

Prior surgery changes the anatomy. Scar tissue and adhesions may affect exposure; the heart, aorta, right ventricle, or bypass grafts may lie near a planned re-entry; and existing valves, grafts, conduits, rings, patches, or devices can change the new operation. The importance of each issue depends on the actual prior operation, current source imaging, and proposed procedure.

A review can be useful when another operation has been proposed, the new procedure is complex or combined, prior operative details are unclear, open and catheter-based paths are both being discussed, a bypass graft or prior implant changes the anatomy, opinions differ, or the patient wants to understand risk and center experience before consent. It should not delay urgent or time-sensitive treatment directed by the treating team.

The full operative report may document the incision, cannulation strategy, coronary-graft origin and route, prosthesis model and size, repair technique, implanted materials, unusual anatomy, technical difficulty, and complications. A clinic note or procedure list may not contain those details. If a report cannot be obtained, the review should state that limit rather than infer missing facts.

The required imaging depends on the problem and proposed operation. It may include echocardiography, gated or nongated chest CT, coronary angiography or CT coronary imaging, MRI, vascular imaging, or device studies. Source images can matter in addition to reports. The treating team decides which studies are clinically necessary and whether contrast, radiation, kidney function, or urgency changes the plan.

A prior graft—especially a patent internal mammary graft—can affect re-entry, exposure, myocardial protection, coronary planning, and the feasibility of alternative access. The review connects the original bypass map with current coronary and graft imaging when available. It cannot determine the dissection technique or guarantee the condition or exact location of a graft at surgery.

Yes, when relevant and documented. The report can organize the type, size, position, age, and known performance of prior valves, rings, aortic grafts or conduits, patches, coronary grafts, pacemakers, defibrillators, and leads. Implant cards and prior reports can help. The review does not independently verify a device model when the source record is incomplete.

Sometimes. Depending on the condition and anatomy, the discussion may include transcatheter valve or valve-in-valve treatment, paravalvular-leak closure, coronary intervention, device treatment, alternative surgical access, medical therapy, infection treatment, or surveillance. None is automatically available or safer. The review explains documented feasibility questions; the treating specialists determine candidacy.

When the proposed procedure fits a validated model and the required inputs are available, an operation-specific STS or other established risk estimate may add population-based context. A score is not a prediction of an individual outcome. Some complex, combined, aortic, infection, device, or unusual reoperations may not fit a model well, and calculators may not fully represent re-entry anatomy, adhesions, graft location, surgeon judgment, frailty, or center resources.

Ask about experience with the specific reoperation being proposed, how the prior reports and source imaging are reviewed, who participates in re-entry and perfusion planning, which multidisciplinary resources are available, and whether comparable public outcomes exist. Case volume alone does not establish quality, and outcomes from one procedure or patient group may not apply to another. WHITEGLOVEMD does not imply a hospital affiliation or guarantee an outcome.

The exact record depends on the case. It commonly includes all prior cardiac operative reports, discharge and complication records, implant or device information, current source imaging and reports, coronary and bypass-graft assessment when relevant, recent clinical and surgical notes, laboratory results, medication and health history, and the complete proposed reoperation. The records team can help identify what is required.

A cardiac surgeon and cardiologist independently review the same complete record, then confer and co-sign one WHITEGLOVE Insights™ report. The surgeon contributes the re-entry, operative, graft, prosthesis, and technical perspective. The cardiologist contributes the imaging, coronary, valve, rhythm, device, medical, and longitudinal perspective.

The WHITEGLOVE Insights™ written review is $495. A live physician consultation is optional, is available at higher service tiers, and is not required to receive the written report. WHITEGLOVEMD is a direct-pay service and does not submit an insurance claim. Current package details are shown before purchase.

The written report is delivered within 24 hours only after every record and source image required for the review has been received and confirmed complete. Time spent identifying, requesting, transferring, or collecting missing prior reports, implant records, or imaging is outside the 24-hour review window.

No. WHITEGLOVEMD provides educational decision support and independent medical-record review. It does not diagnose, prescribe, establish a treating physician–patient relationship, determine procedural candidacy, select an operation or surgeon, perform surgery, provide surgical consent, or replace the clinicians responsible for your care. The decision remains with you and your treating team.